ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

Breast Density As Important As Age In Determining Risk

September 29, 2006

NCI Awards $15M For Studies Of Glycobiology.

September 28, 2007

Support For Translational Researchers Urgently Needed, ASCO President Says

May 22, 1998

In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH

January 20, 1995

Burton’s Clinic Reported Operating In Spite of Closure

December 13, 1985

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989